Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-28Clinical Trial Update: A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of Opzelura (ruxolitinib) cream in adults with moderate atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B) [Phase 1, Phase 2]
This clinical trial update reports the completion of a combined single-ascending-dose (Part A) and repeat-dose (Part B) study of UCB1381 to …
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis [Phase 2]
A Phase 2 proof-of-concept study evaluating BSI-045B for moderate-to-severe atopic dermatitis has completed, with results posted.
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating Lebrikizumab (LY3650150) with or without topical corticosteroids for moderate-to-severe atopic dermatiti…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema [Phase 4]
Phase 4 trial evaluating reducing the dupilumab dose in patients with controlled atopic dermatitis is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis [Phase 1]
This Phase 1 study of LY3872386 in healthy participants and individuals with atopic dermatitis was terminated, and results have been posted …
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis [Phase 3]
Phase 3 trial of CM310 injection in adolescents with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Study of CM310 in Adolescent Subjects With Atopic Dermatis [Phase 3]
A Phase 3 clinical trial evaluating CM310 for adolescent atopic dermatitis is currently ACTIVE_NOT_RECRUITING, indicating the study is ongoi…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Study of LW402 in Moderate-to-Severe Atopic Dermatitis [Phase 2]
Clinical trial update announcing completion of a Phase 2 study of LW402 for moderate-to-severe atopic dermatitis.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis [NA]
This document describes an ongoing clinical trial evaluating the use of CeraVe as a maintenance regimen to restore skin hydration in subject…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A clinical trial evaluating Abrocitinib in adults with moderate to severe atopic dermatitis has been terminated, and the results have been p…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis Skin
This document reports the completion of a trial assessing the tolerance and efficacy of a sunscreen product used in real-world conditions in…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients [Phase 3]
This document reports the completion of a Phase 3 trial comparing methotrexate and cyclosporine in patients with moderate-to-severe atopic d…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: In-Use Tolerance Study Under Dermatological and Pediatric Controls of Sunscreen in Children With Atopic Dermatitis
Completed clinical trial evaluating in-use tolerance of sunscreen under dermatological and pediatric controls in children with atopic dermat…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial is planned to evaluate the efficacy and safety of SIM0278 in adults with moderate to severe Atopic Dermatitis, with…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis [Phase 1]
Phase 1 clinical trial update showing CM512 was studied in healthy subjects and patients with Atopic Dermatitis, and the study status is com…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis [Phase 3]
A Phase 3 trial of OPA-15406 Foam for children and infants with atopic dermatitis is planned and currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of repeat subcutaneous doses of FB825 in adults with moderate-to-severe atopic d…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating MH004 Ointment for mild to moderate atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis [Phase 1]
Phase 1 safety and tolerability data for BSI-045B in healthy adults and patients with atopic dermatitis are presented.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis [Phase 1, Phase 2]
Clinical trial update for MH004 Ointment in healthy volunteers and adults with mild to moderate atopic dermatitis, covering Phase 1 and Phas…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction [NA]
A clinical trial is evaluating a novel skin barrier product against petrolatum for skin barrier dysfunction and is currently recruiting at M…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Clinical Trial to Evaluate the Effect of a Probiotic Mixture in the Treatment of Atopic Dermatitis in Children [NA]
A clinical trial is evaluating a probiotic mixture as a treatment for atopic dermatitis in children. The study is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis [Phase 1]
A Phase 1 clinical trial is evaluating the safety, tolerability, and preliminary efficacy of the investigational drug BxC-I17e given by subc…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study evaluating camoteskimab in adults with moderate to severe atopic dermatitis has completed.